查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1138384

全球生育補充劑市場-2022-2029

Global Fertility Supplements Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

對天然材料不斷增長的需求推動了市場增長。

在預測期內，對生育補充劑的需求預計會增加。老年人口的增長和對預防性醫療保健解決方案的興趣增加是推動全球市場增長的某些因素。隨著教育系統的改進，對天然成分的偏好正在增加。對含有紅三葉草、月見草油和葡萄籽提取物等成分的生育補充劑的需求明顯增加。預計這些努力將對整個市場的增長產生積極影響。

此外，醫生經常推薦生育補充劑來解決不育問題。預計這將對全球市場產生積極影響。

內容

第一章調查方法及範圍

  • 調查方法
  • 市場範圍

第 2 章主要趨勢和發展

第 3 章執行摘要

  • 按成分劃分的市場細分
  • 按產品劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 對天然材料的需求不斷增加具有積極影響
      • 計劃生育法規的變化促進了中國及其他地區的增長
    • 約束因素
      • 對副作用的擔憂增加
    • 商機
  • 影響分析

第五章行業分析

  • 波特五力分析
  • 價值鏈分析
  • 專利分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措

第 7 章按成分分類

  • 自然
  • 合成/混合天然和合成

第 8 章按產品分類

  • 膠囊
  • 粉末
  • 藥片
  • 軟膠囊
  • 液體

第 9 章，最終用戶

  • 男
  • 女性

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 競爭場景
  • 競爭對手戰略分析
  • 市場情況/份額分析
  • 併購分析

第 12 章公司簡介

  • Fairhaven Lenus
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Coast Science Lenus
  • Pharma GmbH
  • Active Bio Life Science GmbH
  • Orthomol
  • Exeltis USA, Inc.
  • PregPrep LLC
  • TTK Healthcare Ltd.
  • Bestmade Natural Products
  • Shenzhen Hemp Bio-Tech Co., Ltd
  • CURIVO HEALTHCARE LLP
  • NUTRIFACTOR LABORATORIES（PVT.）LIMITED
  • Xiamen Yuanzhidao Biotechnology Co., Ltd.

第13章 DataM

簡介目錄
Product Code: DMHCIT3077

Market Overview

Fertility Supplements Market size was valued at USD 1,977.30 million in 2021 and is estimated to reach at a compound annual growth rate (CAGR) of 9.60% over the forecast period 2022 to 2029.

Fertility assists in producing offspring; however, in certain cases, failure in this process leads to infertility. To overcome such issues, there has been developed by pharmaceutical companies with the introduction of medicines in the form of soft gels, capsules, powders, liquids, and others. These drugs assist in treating infertility problems in men and women. Fertility supplements, also termed fertility drugs, are medications that improve reproductive fertility. For women, a fertility supplement is used to promote follicle development of the ovary. The increasing embracing of herbal medicines due to the rising concerns involving the harmful effects linked with conventional pharma drugs is likely to create growth opportunities for product manufacturers. Several government initiatives for generating awareness about innovations in supplement research and superior technology have helped consumers make supplement choices.

Market Dynamics: Rising Demand for Natural Ingredients drives market growth.

The demand for fertility supplements is expected to rise over the forecast period. The rising geriatric population and the increasing interest in preventive healthcare solutions are certain factors encouraging the growth of the market across the globe. With the rise in the education system, there is a rise in the preference for natural ingredients. There is an apparent rise in the demand for fertility supplements that contain ingredients, such as red clover, primrose oil, or grape seed extracts. These efforts are likely to have an encouraging impact on the overall market growth.

Moreover, doctors often recommend fertility supplements to assist couples and parents cope with their fertility concerns. This is expected to have a positive impact on the global market.

However, amendments in family planning regulations in China. With the introduction of the "one-child-per-couple" policy in China, the fertility of women has been negatively impacted.

Market Segmentation: The powder segment accounted for the highest share in global fertility supplements market.

The fertility supplements market has been classified into capsules, tablets, soft gels, powders, and liquids based on the product.

The fertility supplement powder segment dominated the market in 2022. It is owing to increasing awareness regarding the nutritional benefits linked with these products. These products facilitate unique mixes of ingredients, reduce gastrointestinal irritation, and ensure oil and fat-soluble nutrient delivery.

Based on the end-users, the fertility supplements market has been classified into men and women. The men segment accounted significant market share in the fertility supplements market during the forecast period. Immune system factors, varicocele, hypogonadism, systemic disease, urogenital infection, sexual factors, and undescended testicles are some of the major factors leading to fertility problems in men. In the last 50 years, sperm concentration has fallen considerably by 52% among men in Western countries. The drop is alarming as sperm concentration below 40 million per milliliter is considered below normal and can worsen fertility. All these factors have resulted in an increasing demand for fertility supplements for men.

Geographical Penetration: North America is the dominating region during the forecast period.

North America contributed the largest revenue share to the global fertility supplements market in 2022. This dominance is due to the presence of several key market players in the region, especially in the US. Moreover, the increasing health concerns among consumers further support the market growth in the region. Additionally, the growing prevalence of obesity and the rising number of diabetic patients in the region is augmenting the demand for fertility supplements in North America. However, Asia Pacific is projected to grow at the fastest CAGR in the global fertility supplements market over the forecast period. This growth is attributed to the change in the lifestyle of customers and the increase in health consciousness among the consumers. The market in this region is observing a radical transformation regarding rapid urbanization, diet diversification, and liberal trade policies in the food sector. Furthermore, an increase in the inclination of consumers toward healthy food products and a surge in purchasing power are certain factors offering growth opportunities for fertility supplements manufacturers in the region.

Competitive Landscape:

The fertility supplements market is highly competitive, owing to the presence of big food brands. The critical fertility supplements players which are contributing to the growth of the global market include Fairhaven Health, Coast Science Lenus, Pharma GesmbH, Active Bio Life Science GmbH, Orthomol Exeltis USA, Inc. PregPrep LLC, TTK Healthcare Ltd., Best made Natural Products, Curivo Healthcare Llp, Nutrifactor Laboratories (Pvt.) Limited, Xiamen Yuanzhidao Biotechnology Co., Ltd. and Shenzhen Hemp Bio-Tech Co., Ltd., among others. The major players are adopting new launches based on new material launches and expansion strategies for global growth in the fertility supplements market. In August 2022, Youtheory, a supplement brand, expanded its new line of liquid dietary supplements. This company is acquired by Canadian firm Jamieson wellness in a deal of $210 million. In April 2022, Ovaterra launched New Prenatal Vitamins in the market for fertility treatment. The supplements, designed in collaboration with fertility author Rebecca Fett, contain the full recommended daily allowance of choline. These two supplements are named Advanced Prenatal and Advanced Prep 35-39. Advanced Prep 35-39 includes 25mg of patented FERTINATAL, a micronized DHEA and is designed specifically for women aged 35-39, the more advanced reproductive age range.

COVID-19 Impact: Positive impact on the global fertility supplements market.

COVID-19 has led to an increase in fertility supplements amidst the pandemic. The company engaged in the fertility supplements market has witnessed a nominal surge in revenue during the pandemic. This is because COVID-19 certainly impacts the fertility level of a person, owing to which an intake of supplements has increased for fertility supplements post the outbreak of COVID-19.

Table of Contents

1. Scope and Methodology

  • 1.1. Research Methodology
  • 1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

  • 3.1. Market Snippet by Ingredients
  • 3.2. Market Snippet by Product
  • 3.3. Market Snippet by End Use
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market impacting factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Demand for Natural Ingredients to Have a Positive Impact
      • 4.1.1.2. Amendments in Family Planning Regulations to Propel Growth in China and Elsewhere
    • 4.1.2. Restraints
      • 4.1.2.1. Increasing concerns regarding the side effects
    • 4.1.3. Opportunities
  • 4.2. Impact analysis

5. Industry Analysis

  • 5.1. Porter's five forces analysis
  • 5.2. Value chain analysis
  • 5.3. Patent Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives

7. By Ingredients

  • 7.1. Introduction
    • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Ingredients Segment
    • 7.1.2. Market attractiveness index, By Ingredients Segment
  • 7.2. Natural *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 7.3. Synthetic/Blend of Natural & Synthetic

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Product Segment
    • 8.1.2. Market attractiveness index, By Product Segment
  • 8.2. Capsules *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 8.3. Powder
  • 8.4. Tablets
  • 8.5. Soft gels
  • 8.6. Liquids

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market size analysis, and y-o-y growth analysis (%), By End User Segment
    • 9.1.2. Market attractiveness index, By End User Segment
  • 9.2. Men *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 9.3. Women

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key region-specific dynamics
    • 10.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. South America
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.3.6.1. Brazil
      • 10.3.6.2. Argentina
      • 10.3.6.3. Rest of South America
  • 10.4. Europe
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.4.6.1. Germany
      • 10.4.6.2. U.K.
      • 10.4.6.3. France
      • 10.4.6.4. Spain
      • 10.4.6.5. Italy
      • 10.4.6.6. Rest of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Ingredients
    • 10.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product
    • 10.6.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive scenario
  • 11.2. Competitor strategy analysis
  • 11.3. Market positioning/share analysis
  • 11.4. Mergers and acquisitions analysis

12. Company Profiles

  • 12.1. Fairhaven Lenus*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Coast Science Lenus
  • 12.3. Pharma GmbH
  • 12.4. Active Bio Life Science GmbH
  • 12.5. Orthomol
  • 12.6. Exeltis USA, Inc.
  • 12.7. PregPrep LLC
  • 12.8. TTK Healthcare Ltd.
  • 12.9. Bestmade Natural Products
  • 12.10. Shenzhen Hemp Bio-Tech Co., Ltd
  • 12.11. CURIVO HEALTHCARE LLP
  • 12.12. NUTRIFACTOR LABORATORIES (PVT.) LIMITED
  • 12.13. Xiamen Yuanzhidao Biotechnology Co., Ltd.
  • List not Exhaustive*

13. DataM

  • 13.1. Appendix
  • 13.2. About us and services
  • 13.3. Contact us